Successful treatment of resistant Burkholderia multivorans infection in a patient with cystic fibrosis using ceftazidime/avibactam plus aztreonam-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful treatment of resistant Burkholderia multivorans infection in a patient with cystic fibrosis using ceftazidime/avibactam plus aztreonam

Published:2018-04-17 Issue:8 Volume:73 Page:2270-2271
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Barlow Gavin¹²,Morice Alyn²³

Affiliation:

1. The Centre for Immunology and Infection, Hull York Medical School, University of York, Heslington, York, UK

2. Hull and East Yorkshire Hospitals NHS Trust, Castle Hill Hospital, Hull, UK

3. Cardiorespiratory Studies, Hull York Medical School, University of Hull, Castle Hill Hospital, Hull, UK

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/73/8/2270/25178692/dky136.pdf

Reference9 articles.

1. Ceftazidime/avibactam alone or in combination with aztreonam against colistin-resistant and carbapenemase-producing Klebsiella pneumoniae;Jayol;J Antimicrob Chemother,2018

2. Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection;Shaw;J Antimicrob Chemother,2018

3. Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae?;Marshall;Antimicrob Agents Chemother,2017

4. Overcoming an extremely drug resistant (XDR) pathogen: avibactam restores susceptibility to ceftazidime for Burkholderia cepacia complex isolates from cystic fibrosis patients;Papp-Wallace;ACS Infect Dis,2017

5. Effect of β-lactamase inhibitors on in vitro activity of β-lactam antibiotics against Burkholderia cepacia complex species;Everaert;Antimicrob Resist Infect Control,2016

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibiotic Therapy for Difficult-to-Treat Infections in Lung Transplant Recipients: A Practical Approach;Antibiotics;2022-05-02

2. Clinical Eﬃcacy of Ceftazidime-Avibactam in the Treatment of Infections Caused by Carbapenem–Resistant Gram-Negative Bacteria;Antibiotics and Chemotherapy;2021-10-21

3. Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review;Infectious Diseases and Therapy;2021-08-11

4. New β-Lactam–β-Lactamase Inhibitor Combinations;Clinical Microbiology Reviews;2020-12-16

5. New Therapeutic Approaches in Cystic Fibrosis;Turkish Journal of Pharmaceutical Sciences;2020-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3